tirzepatide still available FDA says shortage is over after taking a second look Mounjaro and Zepbound no longer

Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, under active clinical evaluation

doi: 10.1155/2015/948417

Sridhar VS, Dubrofsky L, Boulet J, Cherney DZ

By: Mike Montemarano Associate Editor, Nutraceuticals World Researchers from nutraceutical retailer GNC recently published a new peer-reviewed article in Obesity Pillars highlighting supplements that may be suitable to support those who are taking GLP-1 receptor agonists, such as Ozempic or Wegovy

Minimizing Side Effects Aside from eating well to get the weight loss results you want, eating to manage side effects is really important

The FDA also advised patients to proceed with caution, as some of the compounded semaglutide may not have the same active ingredients as the approved version and may contain salt formulations, which are neither safe nor effective